Yallampalli expression of decay accelerating factor by down-regulating the Escherichia coli + PI 3 K / Akt pathway restricts epithelial adhesion of Dr

The urogenital microbial infection in pregnancy is an important cause of maternal and neonatal morbidity and mortality. Uropathogenic Escherichia coli strains which express Dr fimbriae (Drþ) are associated with unique gestational virulence and they utilize cell surface decay accelerating factor (DAF or CD55) as one of the cellular receptor before invading the epithelial cells. Previous studies in our laboratory established that nitric oxide reduces the rate of E. coli invasion by delocalizing the DAF protein from cell surface lipid rafts and down-regulating its expression. The phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) cell signal pathway plays an important role in host-microbe interaction because many bacteria including E. coli activate this pathway in order to establish infection. In the present study, we showed that the PI3K/Akt pathway negatively regulated the expression of DAF on the epithelial cell surface and thus inhibited the adhesion of Drþ E. coli to epithelial cells. Initially, using two human cell lines Ishikawa and HeLa which differ in constitutive activity of PI3K/Akt, we showed that DAF levels were associated with the PI3K/Akt pathway. We then showed that the DAF gene expression was up-regulated and the Drþ E. coli adhesion increased after the suppression of PI3K/Akt pathway in Ishikawa cells using inhibitor LY294002, and a plasmid which allowed the expression of PI3K/ Akt regulatory protein PTEN. The down-regulation of PTEN protein using PTEN-specific siRNA activated the PI3K/Akt pathway, down-regulated the DAF, and decreased the adhesion of Drþ E. coli. We conclude that the PI3K/Akt pathway regulated the DAF expression in a nitric oxide independent manner.

[1]  G. M. Wilson,et al.  Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide , 2012, The FEBS journal.

[2]  K. Orth,et al.  Manipulation of kinase signaling by bacterial pathogens , 2011, The Journal of cell biology.

[3]  J. Kur,et al.  Analysis of the unique structural and physicochemical properties of the DraD/AfaD invasin in the context of its belonging to the family of chaperone/usher type fimbrial subunits , 2011, BMC Structural Biology.

[4]  T. Korpela,et al.  Adhesive organelles of Gram-negative pathogens assembled with the classical chaperone/usher machinery: structure and function from a clinical standpoint. , 2010, FEMS microbiology reviews.

[5]  J. Kur,et al.  Preclusion of irreversible destruction of Dr adhesin structures by a high activation barrier for the unfolding stage of the fimbrial DraE subunit. , 2009, Biochemistry.

[6]  R. Peek,et al.  Regulation of the Helicobacter pylori Cellular Receptor Decay-accelerating Factor* , 2008, Journal of Biological Chemistry.

[7]  E. Cota,et al.  The solution structure of the invasive tip complex from Afa/Dr fibrils , 2006, Molecular microbiology.

[8]  Li Zhao,et al.  Oncogenic PI3K deregulates transcription and translation , 2005, Nature Reviews Cancer.

[9]  J. Stoute.  Complement-regulatory proteins in severe malaria: too little or too much of a good thing? , 2005, Trends in parasitology.

[10]  A. Servin.  Pathogenesis of Afa/Dr Diffusely Adhering Escherichia coli , 2005, Clinical Microbiology Reviews.

[11]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[12]  Pietro Roversi,et al.  An atomic resolution model for assembly, architecture, and function of the Dr adhesins. , 2004, Molecular cell.

[13]  S. Young,et al.  Epithelial Invasion by Escherichia coli Bearing Dr Fimbriae Is Controlled by Nitric Oxide-Regulated Expression of CD55 , 2004, Infection and Immunity.

[14]  O. Billker,et al.  Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr adhesins of diffusely adhering Escherichia coli (Afa/Dr DAEC) , 2004, Molecular microbiology.

[15]  Jianxin Sun,et al.  Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase Akt Pathway Mediates Nitric Oxide-Induced Endothelial Cell Migration and Angiogenesis , 2003, Molecular and Cellular Biology.

[16]  A. Ronald.  The etiology of urinary tract infection: traditional and emerging pathogens. , 2002, The American journal of medicine.

[17]  T. Tamaya,et al.  PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway , 2002, Cell Death and Differentiation.

[18]  J. Hayakawa,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Regulation of the PRL Promoter by Akt through cAMP Response Element Binding Protein , 2022 .

[19]  R. Selvarangan,et al.  Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. , 2001, The Journal of infectious diseases.

[20]  C. Le Bouguénec,et al.  afa-8 Gene Cluster Is Carried by a Pathogenicity Island Inserted into the tRNAPhe of Human and Bovine Pathogenic Escherichia coli Isolates , 2001, Infection and Immunity.

[21]  S. Moseley,et al.  Recruitment of CD55 and CD66e Brush Border-Associated Glycosylphosphatidylinositol-Anchored Proteins by Members of the Afa/Dr Diffusely Adhering Family of Escherichia coli That Infect the Human Polarized Intestinal Caco-2/TC7 Cells , 2000, Infection and Immunity.

[22]  R. Selvarangan,et al.  Role of Decay-Accelerating Factor Domains and Anchorage in Internalization of Dr-Fimbriated Escherichia coli , 2000, Infection and Immunity.

[23]  L. Twiggs,et al.  Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. , 2000, Gynecologic oncology.

[24]  S. Moseley,et al.  Recruitment of CD 55 and CD 66 e Brush Border-Associated Glycosylphosphatidylinositol-Anchored Proteins by Members of the Afa / Dr Diffusely Adhering Family of Escherichia coli That Infect the Human Polarized Intestinal Caco-2 / TC 7 Cells , 2000 .

[25]  V. Rosti.  The molecular basis of paroxysmal nocturnal hemoglobinuria. , 2000, Haematologica.

[26]  P. Gounon,et al.  Molecular Cloning and Characterization of the afa-7and afa-8 Gene Clusters Encoding Afimbrial Adhesins inEscherichia coli Strains Associated with Diarrhea or Septicemia in Calves , 1999, Infection and Immunity.

[27]  A. Servin,et al.  Piracy of Decay-Accelerating Factor (CD55) Signal Transduction by the Diffusely Adhering Strain Escherichia coli C1845 Promotes Cytoskeletal F-Actin Rearrangements in Cultured Human Intestinal INT407 Cells , 1998, Infection and Immunity.

[28]  S. Varsano,et al.  Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement‐mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance , 1998, Clinical and experimental immunology.

[29]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[30]  C. Yallampalli,et al.  Lethal Outcome of Uterine Infection in Pregnant but Not in Nonpregnant Rats and Increased Death Rate With Inhibition of Nitric Oxide , 1997, American journal of reproductive immunology.

[31]  R. Selvarangan,et al.  Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. , 1997, The Journal of infectious diseases.

[32]  J. Bliska,et al.  Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions , 1997, The EMBO journal.

[33]  L. Truong,et al.  Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. , 1997, The Journal of clinical investigation.

[34]  David R. Kaplan,et al.  Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.

[35]  K. Dimock,et al.  The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55) , 1996, Journal of virology.

[36]  A. Dalmasso,et al.  Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). , 1996, The American journal of pathology.

[37]  B. Nowicki,et al.  Rapid cyclic changes in density and accessibility of endometrial ligands for Escherichia coli Dr fimbriae , 1996, Infection and immunity.

[38]  M. Krohn,et al.  The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group. , 1996, The Journal of infectious diseases.

[39]  C. Bloch,et al.  Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. , 1995, The Journal of infectious diseases.

[40]  B. Morgan,et al.  Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation. , 1995, Immunology.

[41]  P. Fénichel,et al.  [Expression and role of complement regulatory proteins on human gametes and pre-implantation embryos]. , 1995, Contraception, fertilite, sexualite.

[42]  B. Nowicki,et al.  dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor , 1995, Infection and immunity.

[43]  D. Hirsch,et al.  A model of intrauterine infection and preterm delivery in mice. , 1995, American journal of obstetrics and gynecology.

[44]  B. Nowicki,et al.  Decreased expression of endometrial decay accelerating factor (DAF), a complement regulatory protein, in patients with luteal phase defect. , 1995, American journal of reproductive immunology.

[45]  J. Bergelson,et al.  Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55) , 1995, Journal of virology.

[46]  J. Bergelson,et al.  Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  B. Nowicki,et al.  Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction , 1993, The Journal of experimental medicine.

[48]  R. Romero,et al.  A review of premature birth and subclinical infection. , 1992, American journal of obstetrics and gynecology.

[49]  G. Venneker,et al.  CD59: a molecule involved in antigen presentation as well as downregulation of membrane attack complex. , 1992, Experimental and clinical immunogenetics.

[50]  L. Ravi,et al.  Characterization of the decay-accelerating factor gene promoter region. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Kaper,et al.  Diffuse-adhering Escherichia coli (DAEC) as a putative cause of diarrhea in Mayan children in Mexico. , 1991, The Journal of infectious diseases.

[52]  Richard,et al.  The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition , 1990, Infection and Immunity.

[53]  B. Nowicki,et al.  A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen , 1988, Infection and immunity.

[54]  L. Truong,et al.  Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. , 1988, The American journal of pathology.

[55]  M. Nishida,et al.  [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors]. , 1985, Nihon Sanka Fujinka Gakkai zasshi.

[56]  E. Beachey,et al.  Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. , 1981, The Journal of infectious diseases.